Humana Inc. Files 8-K for Regulation FD Disclosure
Ticker: HUM · Form: 8-K · Filed: Sep 3, 2024 · CIK: 49071
| Field | Detail |
|---|---|
| Company | Humana Inc (HUM) |
| Form Type | 8-K |
| Filed Date | Sep 3, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 3 min |
| Key Dollar Amounts | $12.81, $16.00 |
| Sentiment | neutral |
Sentiment: neutral
Topics: regulation-fd, disclosure
TL;DR
Humana filed an 8-K for a Reg FD disclosure - watch for updates.
AI Summary
On September 3, 2024, Humana Inc. filed an 8-K report. The filing primarily serves as a notification of a Regulation FD Disclosure, indicating that the company is releasing material non-public information to the public. No specific financial figures or new business developments were detailed in the provided excerpt.
Why It Matters
This filing signals that Humana Inc. is making a public disclosure of information, which could impact investors' understanding of the company's current status or future outlook.
Risk Assessment
Risk Level: low — The filing is a standard procedural disclosure and does not contain information that inherently increases risk.
Key Numbers
- 001-05975 — Commission File Number (Identifies Humana Inc. in SEC filings)
- 61-0647538 — IRS Employer Identification No. (Tax identification for Humana Inc.)
Key Players & Entities
- Humana Inc. (company) — Registrant
- Delaware (jurisdiction) — State of incorporation
- 500 West Main Street, Louisville, Kentucky 40202 (address) — Principal executive offices
FAQ
What specific information is being disclosed under Regulation FD?
The provided excerpt does not specify the content of the Regulation FD disclosure, only that the filing is intended to satisfy this requirement.
When was the earliest event reported in this 8-K filing?
The earliest event reported is September 3, 2024.
What is Humana Inc.'s principal executive office address?
Humana Inc.'s principal executive offices are located at 500 West Main Street, Louisville, Kentucky 40202.
Under which section of the Securities Exchange Act is this Form 8-K filed?
This Form 8-K is filed pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934.
What is the Standard Industrial Classification code for Humana Inc.?
The Standard Industrial Classification code for Humana Inc. is 6324, which corresponds to Hospital & Medical Service Plans.
Filing Stats: 744 words · 3 min read · ~2 pages · Grade level 13.3 · Accepted 2024-09-03 07:27:27
Key Financial Figures
- $12.81 — reaffirm its guidance of approximately $12.81 in diluted earnings per common share ("
- $16.00 — r common share ("EPS") or approximately $16.00 in adjusted earnings per common share (
Filing Documents
- hum-20240903.htm (8-K) — 32KB
- 0000049071-24-000042.txt ( ) — 153KB
- hum-20240903.xsd (EX-101.SCH) — 2KB
- hum-20240903_lab.xml (EX-101.LAB) — 21KB
- hum-20240903_pre.xml (EX-101.PRE) — 12KB
- hum-20240903_htm.xml (XML) — 3KB
01 Regulation FD Disclosure
Item 7.01 Regulation FD Disclosure. Members of Humana Inc.'s (the "Company") senior management team are scheduled to meet with investors and analysts at industry conferences and various other meetings between September 3, 2024 and September 30, 2024. During these conferences and meetings, the Company intends to reaffirm its guidance of approximately $12.81 in diluted earnings per common share ("EPS") or approximately $16.00 in adjusted earnings per common share ("Adjusted EPS"), in each case for the year ending December 31, 2024 ("FY 2024"). This guidance is consistent with the guidance issued in Humana's press release dated July 31, 2024. The date and time of presentations to investors are available via the Investor Relations calendar of events on the Company's website at www.humana.com. The Company has included Adjusted EPS in this current report, a financial measure that is not in accordance with Generally Accepted Accounting Principles ("GAAP"). Management believes that this measure, when presented in conjunction with the comparable measure of GAAP EPS, provides a comprehensive perspective to more accurately compare and analyze the Company's core operating performance over time. Consequently, management uses Adjusted EPS as a consistent and uniform indicator of the Company's core business operations from period to period, as well as for planning and decision-making purposes and in determination of incentive compensation. Adjusted EPS should be considered in addition to, but not as a substitute for, or superior to, GAAP EPS. A reconciliation of GAAP EPS to Adjusted EPS follows: Diluted earnings per common share FY 2024 Guidance GAAP approximately $12.81 Amortization of identifiable intangibles 0.50 Put/call valuation adjustments associated with Company's non-consolidating minority interest investments 1.65 Impact of exit of employer group commercial medical products business 1.21 Value creation initiatives 0.80 Cumulative net tax impact of non-GAAP ad
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized. HUMANA INC. BY: /s/ John-Paul W. Felter John-Paul W. Felter Senior Vice President, Chief Accounting Officer & Controller (Principal Accounting Officer) Dated: September 3, 2024